Organizations Interested in the ARC™ Model

Since 2004, representatives from the organizations listed below have contacted us to learn more about the model and how it might be used to leverage their own research programs.

Organizations Interested in the ARC™ Model

ABC²
Adelson Medical Research Foundation
Allen Brain Institute
American Cancer Society
American Tinnitus Association
Association of University Technology
Managers (AUTM)
A*STAR Singapore
Australia Spinal Cord Injury Association
Autism Consortium
Bain Consulting
Ben and Catharine Ivy Foundation
Brain Trust Initiative
Buck Institute
California Institute for Regenerative
Medicine
Center for Integration of Medicine and
Innovative Technology
Charcot-Marie-Tooth Association
Connecticut Council for Philanthropy
Cure Autism Now
Deafness Research Foundation
Donaghue Foundation
Down Syndrome Research and Treatment
Foundation
Duke University School of Law
Ernest Gallo Clinic and Research Center
Bill and Melinda Gates Foundation
Faster Cures
Fidelity Foundation
Fogarty Institute for Innovation
Foundation Fighting Blindness
Frontotemporal Dementia Foundation
Funders Collaborative
Goldhirsch Foundation/ Brain Tumor
Grove Foundation

Harvard Stem Cell Institute
Health Research Alliance
Hereditary Neuropathy Foundation
Hide and Seek Foundation
Hopelab
Immune Tolerance Network
Juvenile Diabetes Research Foundation
Lupus Research Institute
Michael J. Fox Foundation
Multiple Myeloma Research Foundation
Myeloproliferative Disorders Foundation
National Academy of Sciences
National Cancer Institute
(U Mass at Amherst)
National Multiple Sclerosis Society
Pacific Vascular Research Foundation
Packard Center for ALS Research
Partnership for Cures
Prader Willi Syndrome
Pritzker Neuropsychiatric Disorders
Consortium
Rett Syndrome Research Foundation
RIVA Foundation
Blanche and Julian Robertson Foundation
Salk Institute
Spinal Muscular Atrophy Foundation
Susan G. Komen for the Cure
Universal Healthcare Foundation
University of California, Office of the
President
University of California, San Francisco
University of Connecticut Medical School
World Ability Federation
Yale University

Our Model = Progress

"The Myelin Repair Foundation's model — which brings together researchers and works to ensure that their work is relevant to development of patient treatments -- is a critical innovation at a time when our system of drug development is looking for new ideas. "

Elliot Gerson
Executive Vice President of Policy and Public Programs, International Partnerships
The Aspen Institute

Make a Donation

Your gift today will help us reach the first myelin repair Phase I Clinical Trial by 2014.